Pfizer's TALZENNA combination shows progress against prostate cancer
Go back to Pfizer's TALZENNA combination shows progress against prostate cancer| Pfizer Inc. (NYSE: PFE) | Delayed: 25.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.70 | 52 Week High | $37.39 | |||
| Open | $25.70 | 52 Week Low | $28.25 | |||
| Day High | $25.70 | P/E | 15.58 | |||
| Day Low | $25.70 | EPS | $1.65 | |||
| Volume | 55,829 | |||||

